CD95/CD95L interactions and their role in autoimmunity

被引:0
|
作者
L. Ricci-Vitiani
C. Conticello
A. Zeuner
R. De Maria
机构
[1] Istituto Superiore di Sanità,Laboratory of Hematology and Oncology
[2] Istituto Superiore di Sanità,Institute of General Pathology
[3] University of Catania,undefined
来源
Apoptosis | 2000年 / 5卷
关键词
apoptosis; diabetes; Fas; organ-specific auto-immunity; thyroiditis;
D O I
暂无
中图分类号
学科分类号
摘要
CD95 (Fas/Apo-1) is a broadly expressed death receptor involved in a variety of physiological and pathological apoptotic processes. Since its discovery, defects in CD95/CD95L system have been proposed as major pathogenic factors responsible for impaired immunological tolerance to self antigens and autoimmunity. Later, analysis of altered sensitivity to CD95-induced apoptosis in cells targeted by the immune response has revealed an unexpected role for CD95 and CD95L in organ-specific autoimmunity. CD95 has been shown to be expressed and functional in virtually all cell types that are target of the organ-specific autoimmune response. Here we review some of the major findings concerning the role of CD95 in autoimmunity, in dysfunctions due to increased or decreased CD95-induced apoptosis.
引用
收藏
页码:419 / 424
页数:5
相关论文
共 50 条
  • [21] Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases
    Risso, Vesna
    Lafont, Elodie
    Le Gallo, Matthieu
    CELL DEATH & DISEASE, 2022, 13 (03)
  • [22] The role of CD95 and CD95 ligand in cancer
    M E Peter
    A Hadji
    A E Murmann
    S Brockway
    W Putzbach
    A Pattanayak
    P Ceppi
    Cell Death & Differentiation, 2015, 22 : 549 - 559
  • [23] The role of CD95 and CD95 ligand in cancer
    Peter, M. E.
    Hadji, A.
    Murmann, A. E.
    Brockway, S.
    Putzbach, W.
    Pattanayak, A.
    Ceppi, P.
    CELL DEATH AND DIFFERENTIATION, 2015, 22 (04): : 549 - 559
  • [24] Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases
    Vesna Risso
    Elodie Lafont
    Matthieu Le Gallo
    Cell Death & Disease, 13
  • [25] Characterization of CD95 ligand (CD95L)-induced apoptosis in human tenon fibroblasts
    Hueber, A
    Welsandt, G
    Jordan, JF
    Mietz, H
    Weller, M
    Krieglstein, GK
    Esser, PJ
    EXPERIMENTAL EYE RESEARCH, 2002, 75 (01) : 1 - 8
  • [26] Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L
    Sigel, JE
    Hsi, ED
    MODERN PATHOLOGY, 2000, 13 (04) : 446 - 451
  • [27] Upregulation of Fas-Fas-L (CD95/CD95L)-mediated epithelial apoptosis - A putative role in pouchitis?
    Coffey, JC
    Bennett, MW
    Wang, JH
    O'Connell, J
    Neary, P
    Shanahan, F
    Redmond, HP
    Kirwan, WO
    JOURNAL OF SURGICAL RESEARCH, 2001, 98 (01) : 27 - 32
  • [28] Evidence for a crucial role of the CD95/CD95L system in ultraviolet light (UV) induced tolerance.
    Schwarz, A
    Riemann, H
    Aragane, Y
    Luger, T
    Grabbe, S
    Schwarz, T
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 3 - 3
  • [29] CD95L/CD95 GENE DELETION DECREASES MOUSE GLIOMA TUMORIGENESIS THROUGH THE INHIBITION OF NON-CANONICAL CD95L/CD95-MEDIATED CELL GROWTH AND IMMUNOSUPPRESSION
    Quijano-Rubio, Clara
    Weller, Michael
    NEURO-ONCOLOGY, 2021, 23 : 37 - 38
  • [30] Carboxy-terminal domain of CD95 suppresses anti-CD95 antibody mediated but not CD95L mediated
    Thilenius, ARB
    Russell, JH
    FASEB JOURNAL, 1996, 10 (06): : 408 - 408